Latest Posts
UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System
DULUTH, GA, & LONDON, UK - August 27, 2026 - Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technologies, today highlighted the recent release of [...]
Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond
Financing will further accelerate the already successful early commercial rollout of VitaSmart™ HOPE System Company also advancing an active organ viability assessment tool designed to raise industry standards with a [...]
New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants
Studies in human uterus and small intestine transplants, including head-to-head comparison with normothermic oxygenated perfusion, presented at 2026 Annual Meeting of the American Transplant Congress (ATC) in Boston Duluth, GA [...]

US Operations:
3300 Breckinridge Blvd. Suite 200 | Duluth, GA 30096 USA
© 2026 Bridge to Life™ Ltd. All rights reserved.
EVENTS
VitaSmart™ is available in Europe, Saudi Arabia, India, and in all countries accepting the CE mark. VitaSmart™ Hypothermic Oxygenated Perfusion System is authorized to be sold in the US market, pending regulatory approval in all other countries.


